tiprankstipranks
Palisade Bio (PALI)
NASDAQ:PALI
Holding PALI?
Track your performance easily

Palisade Bio (PALI) Financial Statements

487 Followers

Palisade Bio Financial Overview

Palisade Bio's market cap is currently ―. The company's EPS TTM is $-15.044; its P/E ratio is -0.12; Palisade Bio is scheduled to report earnings on March 14, 2025, and the estimated EPS forecast is $-2.24. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.48M$ -4.08M$ -3.53M$ -2.97M$ -3.59M
EBITDA$ -3.48M$ -4.08M$ -3.52M$ -2.97M$ -3.59M
Net Income Common Stockholders$ -3.49M$ -4.08M$ -3.53M$ -2.99M$ -3.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.04M$ 11.35M$ 11.28M$ 12.43M$ 15.31M
Total Assets$ 9.34M$ 12.87M$ 12.65M$ 14.05M$ 17.07M
Total Debt$ 122.00K$ 154.00K$ 183.00K$ 211.00K$ 498.00K
Net Debt$ -7.92M$ -11.20M$ -11.09M$ -12.22M$ -14.81M
Total Liabilities$ 2.73M$ 2.92M$ 2.59M$ 2.74M$ 2.98M
Stockholders Equity$ 6.61M$ 9.95M$ 10.06M$ 11.31M$ 14.08M
Cash Flow-
Free Cash Flow$ -3.13M$ -3.50M$ -3.18M$ -2.75M$ -2.66M
Operating Cash Flow$ -3.13M$ -3.50M$ -3.18M$ -2.75M$ -2.66M
Investing Cash Flow-----
Financing Cash Flow$ -180.00K$ 3.58M$ 2.02M$ -134.00K$ 1.57M
Currency in USD

Palisade Bio Earnings and Revenue History

Palisade Bio Debt to Assets

Palisade Bio Cash Flow

Palisade Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis